Slow Progression Of Coronary Artery Disease — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for slow progression of coronary artery disease. 15 active patents protecting 2 drugs from 2+ originators. First major cliff: 2037. Daily refresh.

2
Approved drugs
15
Active US patents
66/100
Avg vulnerability
Annual revenue covered

Originators in Slow Progression Of Coronary Artery Disease

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Merck & Co. 10 patents Pfizer 5 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating slow progression of coronary artery disease. Each bar = one year. Y-axis scaled to peak year (6 patents).

6
26
2
27
2
30
5
37

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Zocor
simvastatin
Merck & Co. 10 70 2026-10-11
Lipitor
Atorvastatin Calcium
Pfizer 5 61 2037-06-07

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
7326708 Zocor other 80 2026-10-11
7326708 Zocor other 80 2026-10-11
7326708 Zocor other 80 2026-10-11
7326708 Zocor other 80 2026-10-11
7326708 Zocor other 80 2026-10-11
7326708 Zocor other 80 2026-10-11
11925704 Lipitor method of use 75 2037-06-07
11654106 Lipitor method of use 70 2037-06-07
10300041 Zocor formulation 60 2027-04-26
10300041 Zocor formulation 60 2027-04-26

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9597289 Zocor formulation 48 2030-02-23
9597289 Zocor formulation 48 2030-02-23
11369567 Lipitor formulation 50 2037-06-07
12370136 Lipitor formulation 55 2037-06-07
12168069 Lipitor formulation 55 2037-06-07
10300041 Zocor formulation 60 2027-04-26
10300041 Zocor formulation 60 2027-04-26
11654106 Lipitor method of use 70 2037-06-07
11925704 Lipitor method of use 75 2037-06-07
7326708 Zocor other 80 2026-10-11

Related